Malcolm G Witter Navidea Biopharmaceuticals, Inc. (NAVB) insider trading activity

NAVB Quotes by TradingView

Malcolm G Witter is Director of NAVIDEA BIOPHARMACEUTICALS, INC.. Currently has a direct ownership of 163,888 shares of NAVB, which is worth approximately $0. The most recent transaction as insider was on Nov 30, 2022, when has been sold 1,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 164K
0% 3M change
0% 12M change
Total Value Held $0

Malcolm G Witter Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 30 2022
BUY
Grant, award, or other acquisition
-
1,250 Added 0.76%
163,888 Common Stock
Oct 31 2022
BUY
Grant, award, or other acquisition
-
2,500 Added 1.5%
163,888 Common Stock
Sep 30 2022
BUY
Grant, award, or other acquisition
-
2,500 Added 1.53%
161,388 Common Stock
Aug 31 2022
BUY
Grant, award, or other acquisition
-
2,500 Added 1.55%
158,888 Common Stock
Jul 31 2022
BUY
Grant, award, or other acquisition
-
2,500 Added 1.57%
156,388 Common Stock
Jun 30 2022
BUY
Grant, award, or other acquisition
-
2,500 Added 1.6%
153,888 Common Stock
May 31 2022
BUY
Grant, award, or other acquisition
-
2,500 Added 1.62%
151,388 Common Stock
Apr 30 2022
BUY
Grant, award, or other acquisition
-
2,500 Added 1.65%
148,888 Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
-
2,500 Added 1.68%
146,388 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
-
2,500 Added 1.71%
143,888 Common Stock
Jan 31 2022
BUY
Grant, award, or other acquisition
-
2,500 Added 1.74%
141,388 Common Stock
Dec 31 2021
BUY
Grant, award, or other acquisition
-
2,500 Added 1.77%
138,888 Common Stock
Nov 30 2021
BUY
Grant, award, or other acquisition
-
1,250 Added 0.91%
136,388 Common Stock
Nov 15 2021
BUY
Grant, award, or other acquisition
-
32,886 Added 19.57%
135,138 Common Stock
Sep 30 2021
BUY
Grant, award, or other acquisition
-
3,995 Added 3.76%
102,252 Common Stock
Sep 17 2021
BUY
Open market or private purchase
$32,000 $1.6 p/Share
20,000 Added 16.91%
98,257 Common Stock
Jul 26 2021
BUY
Open market or private purchase
$25,500 $1.7 p/Share
15,000 Added 16.08%
78,257 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
-
3,757 Added 5.61%
63,257 Common Stock
Apr 23 2021
BUY
Open market or private purchase
$16,000 $1.6 p/Share
10,000 Added 14.93%
57,000 Common Stock
Mar 29 2021
BUY
Open market or private purchase
$44,505 $2.07 p/Share
21,500 Added 31.39%
47,000 Common Stock
Mar 03 2021
BUY
Open market or private purchase
$34,650 $2.31 p/Share
15,000 Added 37.04%
25,500 Common Stock
Jan 13 2021
BUY
Grant, award, or other acquisition
-
2,500 Added 16.13%
13,000 Common Stock
Dec 28 2020
BUY
Open market or private purchase
$10,350 $2.07 p/Share
5,000 Added 32.26%
10,500 Common Stock
MGW

Malcolm G Witter

Director
Dublin, OH

Track Institutional and Insider Activities on NAVB

Follow NAVIDEA BIOPHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NAVB shares.

Notify only if

Insider Trading

Get notified when an Navidea Biopharmaceuticals, Inc. insider buys or sells NAVB shares.

Notify only if

News

Receive news related to NAVIDEA BIOPHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NAVB